262 related articles for article (PubMed ID: 25553408)
1. Taking the fuel out of the fire: evidence for the use of anti-inflammatory agents in the treatment of bipolar disorders.
Ayorech Z; Tracy DK; Baumeister D; Giaroli G
J Affect Disord; 2015 Mar; 174():467-78. PubMed ID: 25553408
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory agents in the treatment of bipolar depression: a systematic review and meta-analysis.
Rosenblat JD; Kakar R; Berk M; Kessing LV; Vinberg M; Baune BT; Mansur RB; Brietzke E; Goldstein BI; McIntyre RS
Bipolar Disord; 2016 Mar; 18(2):89-101. PubMed ID: 26990051
[TBL] [Abstract][Full Text] [Related]
3. Targeting the immune system in the treatment of bipolar disorder.
Rosenblat JD
Psychopharmacology (Berl); 2019 Oct; 236(10):2909-2921. PubMed ID: 30756134
[TBL] [Abstract][Full Text] [Related]
4. Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis.
Sidor MM; Macqueen GM
J Clin Psychiatry; 2011 Feb; 72(2):156-67. PubMed ID: 21034686
[TBL] [Abstract][Full Text] [Related]
5. Atypical antipsychotics for bipolar disorder.
Yatham LN
Psychiatr Clin North Am; 2005 Jun; 28(2):325-47. PubMed ID: 15826735
[TBL] [Abstract][Full Text] [Related]
6. Adjunctive nutraceuticals with standard pharmacotherapies in bipolar disorder: a systematic review of clinical trials.
Sarris J; Mischoulon D; Schweitzer I
Bipolar Disord; 2011; 13(5-6):454-65. PubMed ID: 22017215
[TBL] [Abstract][Full Text] [Related]
7. Relative effectiveness of adjunctive risperidone on manic and depressive symptoms in mixed mania.
Singh V; Bowden CL; Mintz J
Int Clin Psychopharmacol; 2013 Mar; 28(2):91-5. PubMed ID: 23238761
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial.
Berk M; Dean O; Cotton SM; Gama CS; Kapczinski F; Fernandes BS; Kohlmann K; Jeavons S; Hewitt K; Allwang C; Cobb H; Bush AI; Schapkaitz I; Dodd S; Malhi GS
J Affect Disord; 2011 Dec; 135(1-3):389-94. PubMed ID: 21719110
[TBL] [Abstract][Full Text] [Related]
9. Treating mixed mania/hypomania: a review and synthesis of the evidence.
Takeshima M
CNS Spectr; 2017 Apr; 22(2):177-185. PubMed ID: 28004626
[TBL] [Abstract][Full Text] [Related]
10. A Randomized, Double-Blind Placebo-Controlled Trial on Effectiveness and Safety of Celecoxib Adjunctive Therapy in Adolescents with Acute Bipolar Mania.
Mousavi SY; Khezri R; Karkhaneh-Yousefi MA; Mohammadinejad P; Gholamian F; Mohammadi MR; Zeinoddini A; Akhondzadeh S
J Child Adolesc Psychopharmacol; 2017 Aug; 27(6):494-500. PubMed ID: 28409660
[TBL] [Abstract][Full Text] [Related]
11. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
[TBL] [Abstract][Full Text] [Related]
12. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
Vieta E; Owen R; Baudelet C; McQuade RD; Sanchez R; Marcus RN
Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835
[TBL] [Abstract][Full Text] [Related]
13. Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature.
Goldstein BI; Kemp DE; Soczynska JK; McIntyre RS
J Clin Psychiatry; 2009 Aug; 70(8):1078-90. PubMed ID: 19497250
[TBL] [Abstract][Full Text] [Related]
14. N-acetylcysteine for major depressive episodes in bipolar disorder.
Magalhães PV; Dean OM; Bush AI; Copolov DL; Malhi GS; Kohlmann K; Jeavons S; Schapkaitz I; Anderson-Hunt M; Berk M
Braz J Psychiatry; 2011 Dec; 33(4):374-8. PubMed ID: 22189927
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of antimanic treatments in mixed states.
McIntyre RS; Yoon J
Bipolar Disord; 2012 May; 14 Suppl 2():22-36. PubMed ID: 22510034
[TBL] [Abstract][Full Text] [Related]
16. Topiramate for acute affective episodes in bipolar disorder.
Vasudev K; Macritchie K; Geddes J; Watson S; Young A
Cochrane Database Syst Rev; 2006 Jan; (1):CD003384. PubMed ID: 16437453
[TBL] [Abstract][Full Text] [Related]
17. Omega-3 fatty acid treatment, with or without cytidine, fails to show therapeutic properties in bipolar disorder: a double-blind, randomized add-on clinical trial.
Murphy BL; Stoll AL; Harris PQ; Ravichandran C; Babb SM; Carlezon WA; Cohen BM
J Clin Psychopharmacol; 2012 Oct; 32(5):699-703. PubMed ID: 22926607
[TBL] [Abstract][Full Text] [Related]
18. N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial.
Berk M; Copolov DL; Dean O; Lu K; Jeavons S; Schapkaitz I; Anderson-Hunt M; Bush AI
Biol Psychiatry; 2008 Sep; 64(6):468-75. PubMed ID: 18534556
[TBL] [Abstract][Full Text] [Related]
19. Treatments for late-life bipolar disorder.
Aziz R; Lorberg B; Tampi RR
Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
[TBL] [Abstract][Full Text] [Related]
20. [Non-conventional pharmacological agents for the treatment of bipolar disorder: Α systematic review of the evidence].
Fountoulakis KN; Balaris D; Nikolaou V; Νimatoudis J
Psychiatriki; 2016; 27(4):253-263. PubMed ID: 28114089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
